Last reviewed · How we verify

NCT05177952

Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis

Completed NA Last updated 11 June 2024
What this trial tests

NA trial testing Blood Flow Restriction in Training Study in 20 participants. Completed in 31 May 2024.

Timeline
1 January 2022
Primary endpoint
31 January 2024
31 May 2024

Quick facts

Lead sponsorUniversity of Central Florida
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 January 2022
Primary completion31 January 2024
Estimated completion31 May 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Central Florida

Who can join

Adults 18 to 55, female only, with Training Study or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is being done to compare the current standard of care for strength training for patients with Multiple Sclerosis to lightweight resistance training with blood flow restriction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood Flow Restriction

Trials testing the same drug.

Other University of Central Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05177952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing